Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Patient Cohort of the National Center for Precision Medicine in Leukemia

NCT05326919 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT05326919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05326919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Patient Cohort of the National Center for Precision Medicine in Leukemia
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Recruiting
Start date
March 28, 2022
Completion date
March 31, 2042
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, high-risk myelodysplastic syndrome, myeloproliferative neoplasm, unclassifiable, secondary myelofibrosis in myeloproliferative disease